The Columbian
November 05, 2022
OHSU is the second center in the country to implant interneurons in the brain as part of a clinical trial to treat an intractable form of epilepsy. Kim Burchiel, M.D., says he is optimistic the procedure will become a more routine option along with current standard forms of surgical intervention, including implanted stimulators or resection. He says, “Where I see us moving now is into more of what I would call the restorative era. Neural restoration – the idea being, don’t remove it, don’t necessarily use electrical impulses to try to modify it – but try to restore it. And that, to me, I think it’s the Holy Grail right now of what we do in neurology and neurosurgery.”